A new IFPMA study(1), announced at the "Options for the Control of Influenza VII" conference in Hong Kong, shows that global vaccine coverage remains uneven and low overall, despite total distribution of seasonal influenza vaccines nearly doubling over the last six years. The (…)
[Read article]
[Source: Medical News Today]
Highlighted Links Bausch + Lomb ROCHESTER, NY-(Marketwire - September 3, 2010) - Bausch + Lomb, the global eye health company, has announced that it has concluded its acquisition of a portion of the assets and intellectual property for Miochol-E from Affiliates of Novartis AG. (…)
[Read article]
[Source: Marketwire]
Scientists are developing a new antimalarial drug with a novel mechanism of action which shows promise for clearing a Plasmodium (malaria parasite) infection after a single dose, according to an article published in the journal Science. Scientists say the antimalarial (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/60383e/thailand_pharmaceu) has announced the addition of the "Thailand Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Thailand Pharmaceuticals and Healthcare (…)
[Read article]
[Source: Business Wire]
ROCHESTER, NY-(Marketwire - September 03, 2010) - Highlighted Links Bausch + Lomb Bausch + Lomb, the global eye health company, has announced that it has concluded its acquisition of a portion of the assets and intellectual property for Miochol-E from Affiliates of Novartis (…)
[Read article]
[Source: BioSpace]
ScienceDaily (Sep. 2, 2010) An international team led by scientists from The Scripps Research Institute, the Swiss Tropical Institute, the Genomics Institute of the Novartis Research Foundation and the Novartis Institute for Tropical Diseases has discovered a promising new drug (…)
[Read article]
[Source: ScienceDaily]
ScienceDaily (Sep. 2, 2010) Scripps Research Institute scientists have identified two proteins with potential to be important targets for research into a wide range of health problems, including pain, deafness, and cardiac and kidney dysfunction. See Also: Health & Medicine (…)
[Read article]
[Source: ScienceDaily]
The Swiss health authority Swissmedic has granted approval for Tasigna (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna is the first new (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/886118/trends_in_generics) has announced the addition of the "Trends in Generics Industry Ownership: Evaluating Changing Industry Paradigms and Emerging Players" report to their offering. (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/ebf598/norway_pharmaceuti) has announced the addition of the "Norway Pharmaceutical Market Analysis, 2010-2014" report to their offering. Having displayed fluctuating growth rates in the (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/2745c9/argentina_pharmace) has announced the addition of the "Argentina Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Argentina Pharmaceuticals and Healthcare (…)
[Read article]
[Source: Business Wire]
Malaysia Considers GM Mosquito Release To Control Dengue Fever Malaysia is still "considering releasing" up to 3,000 mosquitoes that are genetically modified to "combat dengue fever, in a landmark field trial that has come in for criticism from environmentalists," Agence (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/66a1b1/philippines_pharma) has announced the addition of the "Philippines Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Philippines Pharmaceuticals and (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/c31cef/australia_pharmace) has announced the addition of the "Australia Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Australia Pharmaceuticals and Healthcare (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/23871e/nigeria_pharmaceut) has announced the addition of the "Nigeria Pharmaceuticals and Healthcare Report Q4 2010" report to their offering. Nigeria Pharmaceuticals and Healthcare Report (…)
[Read article]
[Source: Business Wire]
MILL VALLEY, Calif. - March 26, 2010 - BioCision LLC today announced that it has signed a European distribution agreement with SERVA Electrophoresis, a global supplier of reagents for scientific research. SERVA Electrophoresis will sell BioCision s entire portfolio of (…)
[Read article]
[Source: BioSpace]
MILL VALLEY, Calif. February 11, 2010 - BioCision LLC, the CoolRack ¢ company, announced today that it has entered into a distribution agreement with Biophoretics, a developer and distributor of advanced tools for scientific research. Biophoretics will sell BioCision s entire (…)
[Read article]
[Source: BioSpace]
MILL VALLEY, Calif. - BioCision LLC, the CoolRack ¢ company, announced today that is has reached an agreement with Capital Biosciences Inc. for the distribution of BioCision's products, which standardize the handling and processing of temperature-sensitive samples. Capital (…)
[Read article]
[Source: BioSpace]
31.08.2010 - Swissmedic has granted approval for Tasigna (nilotinib) 300 mg twice daily for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase. Tasigna is the first new therapeutic option (…)
[Read article]
[Source: Bionity.com]
31.08.2010 - The US Food and Drug Administration (FDA) approved Tekamlo (aliskiren and amlodipine) tablets, a single-pill for the treatment of high blood pressure combining the only approved direct renin inhibitor, Tekturna (aliskiren) with the widely used calcium channel (…)
[Read article]
[Source: Bionity.com]
BRISTOL, TN-(Marketwire - August 30, 2010) - King Pharmaceuticals, Inc. (NYSE: KG) announced today the appointment of Jeffrey A. Bailey to the position of Chief Commercial Officer. Mr. Bailey will be responsible for the Company's commercial activities in the branded (…)
[Read article]
[Source: Marketwire]
At the NACDS Pharmacy & Technology Conference, taking place August 28-31 in San Diego, Calif., Cardinal Health will encourage attendees to learn more about how they can get involved in the fight against prescription drug abuse. Today, prescription medication abuse is a (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/37adf0/eli_lilly_co_p) has announced the addition of the "Eli Lilly & Co.: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/b87073/sweden_pharmaceuti) has announced the addition of the "Sweden Pharmaceutical Market Analysis, 2010-2014" report to their offering. Having displayed fluctuating growth rates in the (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/a9fe9d/novartis_ag_pharm) has announced the addition of the "Novartis AG: PharmaVitae Profile" company profile to their offering. This analysis examines the historical and forecast (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their Dermatology research database. The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not otherwise visible - (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/aabcf1/johnson_johnson) has announced the addition of the "Johnson & Johnson: PharmaVitae Profile" company profile to their offering. Introduction This analysis examines the historical and (…)
[Read article]
[Source: Business Wire]
MILL VALLEY, Calif., March 31 /PRNewswire/ - BioCision LLC today announced that it has agreed to a co-promotion program with Biohit Inc. (www.us.biohit.com). Biohit's ErgoTube microcentrifuge tubes will now be branded and sold by both Biohit Inc. and BioCision. In addition, (…)
[Read article]
[Source: BioSpace]
STOCKHOLM, SWEDEN-(Marketwire - August 30, 2010) - Portola Pharmaceuticals, Inc. today announced results from the Phase 2 INNOVATE-PCI study of its investigational antiplatelet drug, elinogrel, the only competitive, reversible direct-acting P2Y12 ADP receptor antagonist. (…)
[Read article]
[Source: BioSpace]
30.08.2010 - Novartis announced that it has completed its purchase of Alcon stock from Nestl resulting in 77% ownership of Alcon. This has been achieved by completing the acquisition of the remaining 52% of Alcon shares owned by Nestl for a total of USD 28.3 billion. Alcon (…)
[Read article]
[Source: Bionity.com]
STOCKHOLM, SWEDEN-(Marketwire - August 29, 2010) - Portola Pharmaceuticals, Inc. today announced additional pharmacodynamic data from a pre-specified analysis of EXPLORE-Xa, a Phase 2 dose-finding study of betrixaban, an investigational oral direct Factor Xa inhibitor. During (…)
[Read article]
[Source: Marketwire]
Novartis' single pill combination of aliskiren and amlopidine - Tekamlo - has been approved by the Food and Drug Administration (FDA) for the treatment of hypertension. Data revealed that Tekamlo significantly reduced blood pressure compared to amlodipine or aliskiren (…)
[Read article]
[Source: Medical News Today]
EAST HANOVER, NJ-(Marketwire - August 27, 2010) - Tekamlo combines in a single-pill the only approved direct renin inhibitor, Tekturna, with the widely prescribed calcium channel blocker, amlodipine Data showed Tekamlo significantly reduced blood pressure compared to (…)
[Read article]
[Source: Marketwire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/db0b08/type_2_diabetes) has announced the addition of GlobalData 's new report "Type 2 Diabetes - Pipeline Assessment and Market Forecasts to 2017" to their offering. Type 2 Diabetes - (…)
[Read article]
[Source: Business Wire]
Context: The successful accurate dosing and filling of powders at fill masses of
[Read article]
[Source: NCBI PubMed]
OBJECTIVE.: To evaluate changes in vascular and musculoskeletal involvement in subjects in the Scleroderma Lung Study (SLS), a multicenter, double-blind, randomized, controlled trial comparing placebo treatment to oral cyclophosphamide for 1 year in systemic sclerosis (SSc) (…)
[Read article]
[Source: NCBI PubMed]
Membrane glycoproteins of alphavirus play a critical role in the assembly and budding of progeny virions. However, knowledge regarding transport of viral glycoproteins to the plasma membrane is obscure. In this study, we investigate the role of cytopathic vacuole type II (…)
[Read article]
[Source: NCBI PubMed]
ScienceDaily (Aug. 26, 2010) After more than a decade of research, Scripps Research Institute scientists have pieced together the structure of a human adenovirus - the largest complex ever determined at atomic resolution. The new findings about the virus, which causes (…)
[Read article]
[Source: ScienceDaily]
Keystone Symposia on Molecular and Cellular Biology will convene its conference on "Immunological Mechanisms of Vaccination" in Seattle, Washington from October 27 to November 1, 2010 at Sheraton Seattle Hotel. This is the first conference of Keystone Symposia's 40th meeting (…)
[Read article]
[Source: Medical News Today]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/e03d6e/world_pharmaceutic) has announced the addition of the "World Pharmaceutical Market Analysis - A Digest Guide, 2010-2014" report to their offering. World Pharmaceutical Market (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Research and Markets (http:/www.researchandmarkets.com/research/614240/fixed_dose_combina) has announced the addition of the "Fixed Dose Combination Products" report to their offering. Fixed dose combination (FDC) products are becoming increasingly (…)
[Read article]
[Source: Business Wire]
DUBLIN-(BUSINESS WIRE)-Maven Semantic (http:/www.mavensemantic.com) announces updates to their Genetically Modified Organisms research database. The system uses the context in which a given person appears, using artificial intelligence techniques to find out information not (…)
[Read article]
[Source: Business Wire]